1. Home
  2. BRO vs DXCM Comparison

BRO vs DXCM Comparison

Compare BRO & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRO
  • DXCM
  • Stock Information
  • Founded
  • BRO 1939
  • DXCM 1999
  • Country
  • BRO United States
  • DXCM United States
  • Employees
  • BRO N/A
  • DXCM N/A
  • Industry
  • BRO Specialty Insurers
  • DXCM Medical/Dental Instruments
  • Sector
  • BRO Finance
  • DXCM Health Care
  • Exchange
  • BRO Nasdaq
  • DXCM Nasdaq
  • Market Cap
  • BRO 29.5B
  • DXCM 28.0B
  • IPO Year
  • BRO N/A
  • DXCM 2005
  • Fundamental
  • Price
  • BRO $100.93
  • DXCM $75.26
  • Analyst Decision
  • BRO Buy
  • DXCM Buy
  • Analyst Count
  • BRO 13
  • DXCM 17
  • Target Price
  • BRO $110.08
  • DXCM $98.00
  • AVG Volume (30 Days)
  • BRO 1.2M
  • DXCM 3.3M
  • Earning Date
  • BRO 01-21-2025
  • DXCM 02-06-2025
  • Dividend Yield
  • BRO 0.59%
  • DXCM N/A
  • EPS Growth
  • BRO 39.49
  • DXCM 83.21
  • EPS
  • BRO 3.67
  • DXCM 1.67
  • Revenue
  • BRO $4,558,700,000.00
  • DXCM $3,954,000,000.00
  • Revenue This Year
  • BRO $14.04
  • DXCM $13.10
  • Revenue Next Year
  • BRO $8.86
  • DXCM $14.79
  • P/E Ratio
  • BRO $27.50
  • DXCM $45.13
  • Revenue Growth
  • BRO 11.36
  • DXCM 16.19
  • 52 Week Low
  • BRO $69.19
  • DXCM $62.34
  • 52 Week High
  • BRO $114.15
  • DXCM $142.00
  • Technical
  • Relative Strength Index (RSI)
  • BRO 28.76
  • DXCM 46.07
  • Support Level
  • BRO $103.41
  • DXCM $75.05
  • Resistance Level
  • BRO $105.03
  • DXCM $78.38
  • Average True Range (ATR)
  • BRO 1.81
  • DXCM 2.30
  • MACD
  • BRO -1.01
  • DXCM -0.58
  • Stochastic Oscillator
  • BRO 0.47
  • DXCM 2.91

About BRO Brown & Brown Inc.

Brown & Brown Inc is an insurance agent and broker that offers insurance products and services, primarily in the areas of property, casualty, and employee benefits, by connecting customers with insurance companies. It earns its revenue via commissions from insurance companies and direct fees from customers, and it generally has no underwriting risk exposure. More than half of its revenue is from its retail segment, which provides a broad range of insurance products and services to entities and individuals. Roughly a fourth of revenue is from its national programs segment, which provides, among other things, professional liability coverage for professionals. The company operates primarily in the United States, with its highest exposure in Florida.

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: